Risks
4 risks
Risk Intelligence
Glen Eagles O&M contract profitability may be limited
View Risks →Fortis Healthcare Limited — Q1 FY26
Fortis Healthcare delivered a strong Q1 FY26 with consolidated revenue of INR 2,167 crore (+16.6% YoY) and EBITDA of INR 491 crore (+43.2% YoY), driving margin expansion of 420bps to 22.6%.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Fortis Healthcare delivered a strong Q1 FY26 with consolidated revenue of INR 2,167 crore (+16.6% YoY) and EBITDA of INR 491 crore (+43.2% YoY), driving margin expansion of 420bps to 22.6%. The hospital business led growth with revenue up 18.6% to INR 1,838 crore, supported by ARPOB growth of 10.2% to INR 2.65 lakh per occupied bed per month, driven by a favorable case mix (oncology +28% YoY, robotic surgeries +75% YoY) and occupancy improvement to 69%. Diagnostics (Agilus) saw margin recovery to 23% (vs 16.1% YoY) on gross revenue of INR 369 crore (+7.4% YoY). Management maintained guidance of 200bps margin expansion for FY26, with 900 beds to be added this year. The Glen Eagles O&M contract (3% of net revenue) adds ~INR 20-25 crore EBITDA annually. Key risks include slower-than-expected ramp-up of new beds and potential dilution from the Glen Eagles contract if profitability improvement lags.
फोर्टिस हेल्थकेयर ने पहली तिमाही में अच्छा प्रदर्शन किया। कंपनी की कुल कमाई 2,167 करोड़ रुपये रही, जो पिछले साल से 16.6% ज्यादा है। कमाई पर खर्च घटाने के बाद बचा मुनाफा (EBITDA) 491 करोड़ रुपये रहा, जो 43.2% बढ़ा। अस्पतालों से कमाई 18.6% बढ़कर 1,838 करोड़ रुपये हुई। हर बिस्तर से हर महीने औसत कमाई 2.65 लाख रुपये रही। कैंसर और रोबोटिक सर्जरी के मामले बढ़े। डायग्नोस्टिक्स (एगिलस) का मुनाफा 23% पर पहुंच गया। कंपनी इस साल 900 नए बिस्तर जोड़ेगी। ग्लेन ईगल्स के ठेके से हर साल 20-25 करोड़ रुपये का अतिरिक्त मुनाफा मिलेगा। जोखिम: नए बिस्तरों से उम्मीद के मुताबिक कमाई न होना।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
ARPOB (Average Revenue Per Occupied Bed per month)
INR 2.65 lakh
+10.2% YoY
Driven by improved specialty mix and higher share of complex cases.
Occupancy Rate
69%
+2pp YoY
Occupied beds increased 7.8% to 2,928, reflecting steady demand.
Robotic Surgeries Growth
75% YoY
+75% YoY
High-growth area; 15 robots installed, 4 more planned this year.
Diagnostics EBITDA Margin (Gross Revenue)
23%
+690bps YoY
Sharp improvement from 16.1% in Q1 FY25; guided 22-23% for FY26.
Fast read
Guidance and risk preview
Management reiterated guidance of 200bps margin improvement for the full year, despite a strong Q1.
The contract is based on a 3% revenue fee, not profit share; if underlying hospital margins remain low, Fortis may not capture full upside.
View Risks →